GIKLY
Price
$6.14
Change
+$0.99 (+19.22%)
Updated
Jun 12 closing price
Capitalization
8.78B
22 days until earnings call
KYKOF
Price
$14.95
Change
-$2.19 (-12.78%)
Updated
Jun 25 closing price
Capitalization
10.37B
Interact to see
Advertisement

GIKLY vs KYKOF

Header iconGIKLY vs KYKOF Comparison
Open Charts GIKLY vs KYKOFBanner chart's image
Grifols Sa
Price$6.14
Change+$0.99 (+19.22%)
Volume$916
Capitalization8.78B
Kyowa Hakko Kogyo
Price$14.95
Change-$2.19 (-12.78%)
Volume$1.25K
Capitalization10.37B
GIKLY vs KYKOF Comparison Chart in %
Loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYKOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIKLY vs. KYKOF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIKLY is a Hold and KYKOF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (GIKLY: $6.14 vs. KYKOF: $14.95)
Brand notoriety: GIKLY and KYKOF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIKLY: 154% vs. KYKOF: 48%
Market capitalization -- GIKLY: $8.78B vs. KYKOF: $10.37B
GIKLY [@Pharmaceuticals: Major] is valued at $8.78B. KYKOF’s [@Pharmaceuticals: Major] market capitalization is $10.37B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIKLY’s FA Score shows that 1 FA rating(s) are green whileKYKOF’s FA Score has 2 green FA rating(s).

  • GIKLY’s FA Score: 1 green, 4 red.
  • KYKOF’s FA Score: 2 green, 3 red.
According to our system of comparison, KYKOF is a better buy in the long-term than GIKLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIKLY’s TA Score shows that 4 TA indicator(s) are bullish while KYKOF’s TA Score has 4 bullish TA indicator(s).

  • GIKLY’s TA Score: 4 bullish, 3 bearish.
  • KYKOF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, GIKLY is a better buy in the short-term than KYKOF.

Price Growth

GIKLY (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while KYKOF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.86%. For the same industry, the average monthly price growth was +0.39%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

GIKLY is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.86% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYKOF($10.4B) has a higher market cap than GIKLY($8.79B). GIKLY has higher P/E ratio than KYKOF: GIKLY (75.19) vs KYKOF (29.33). GIKLY YTD gains are higher at: 30.638 vs. KYKOF (-0.327). KYKOF has higher annual earnings (EBITDA): 83.6B vs. GIKLY (726M). KYKOF has more cash in the bank: 347B vs. GIKLY (557M). KYKOF has less debt than GIKLY: KYKOF (5.55B) vs GIKLY (10.9B). KYKOF has higher revenues than GIKLY: KYKOF (404B) vs GIKLY (6.46B).
GIKLYKYKOFGIKLY / KYKOF
Capitalization8.79B10.4B84%
EBITDA726M83.6B1%
Gain YTD30.638-0.327-9,379%
P/E Ratio75.1929.33256%
Revenue6.46B404B2%
Total Cash557M347B0%
Total Debt10.9B5.55B197%
FUNDAMENTALS RATINGS
GIKLY vs KYKOF: Fundamental Ratings
GIKLY
KYKOF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
87100
PRICE GROWTH RATING
1..100
4062
P/E GROWTH RATING
1..100
9631
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KYKOF's Valuation (19) in the null industry is in the same range as GIKLY (21). This means that KYKOF’s stock grew similarly to GIKLY’s over the last 12 months.

KYKOF's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that KYKOF’s stock grew similarly to GIKLY’s over the last 12 months.

GIKLY's SMR Rating (87) in the null industry is in the same range as KYKOF (100). This means that GIKLY’s stock grew similarly to KYKOF’s over the last 12 months.

GIKLY's Price Growth Rating (40) in the null industry is in the same range as KYKOF (62). This means that GIKLY’s stock grew similarly to KYKOF’s over the last 12 months.

KYKOF's P/E Growth Rating (31) in the null industry is somewhat better than the same rating for GIKLY (96). This means that KYKOF’s stock grew somewhat faster than GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIKLYKYKOF
RSI
ODDS (%)
Bearish Trend 5 days ago
78%
Bullish Trend 5 days ago
22%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
61%
Bullish Trend 5 days ago
32%
Momentum
ODDS (%)
Bullish Trend 5 days ago
64%
Bearish Trend 5 days ago
38%
MACD
ODDS (%)
Bearish Trend 5 days ago
64%
Bearish Trend 5 days ago
24%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
54%
Bullish Trend 5 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
56%
Bearish Trend 5 days ago
37%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
27%
Aroon
ODDS (%)
Bullish Trend 5 days ago
65%
Bullish Trend 5 days ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYKOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOT2.250.12
+5.63%
Lotus Technology
MODV3.250.11
+3.50%
ModivCare
GANX1.690.06
+3.36%
Gain Therapeutics
CIEN81.381.86
+2.34%
Ciena Corp
VERA23.65N/A
N/A
Vera Therapeutics

GIKLY and

Correlation & Price change

A.I.dvisor tells us that GIKLY and OPHLY have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIKLY and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
N/A
OPHLY - GIKLY
10%
Poorly correlated
-0.85%
GLAXF - GIKLY
8%
Poorly correlated
-1.56%
NVSEF - GIKLY
7%
Poorly correlated
-3.76%
ORINY - GIKLY
4%
Poorly correlated
N/A
KYKOF - GIKLY
3%
Poorly correlated
N/A
More

KYKOF and

Correlation & Price change

A.I.dvisor tells us that KYKOF and OPHLY have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYKOF and OPHLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYKOF
1D Price
Change %
KYKOF100%
N/A
OPHLY - KYKOF
11%
Poorly correlated
-0.85%
NVSEF - KYKOF
5%
Poorly correlated
-3.76%
HAWPF - KYKOF
5%
Poorly correlated
N/A
GIKLY - KYKOF
3%
Poorly correlated
N/A
OPHLF - KYKOF
-2%
Poorly correlated
N/A
More